5/24/2019  9:59:57 PM Chg. -0.55 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
102.34USD -0.53% 31,343
Turnover: 3.23 mill.
-Bid Size: - -Ask Size: - 49.01 bill.USD 0.53% 34.59

Business description

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
 

Management board & Supervisory board

CEO
Juan Ramón Alaix
Management board
Glenn David, Andrew Fenton, Catherine Knupp, Clinton Lewis, Jr., Heidi Chen, Kristin Peck, Roman Trawicki, Roxanne Lagano
Supervisory board
Michael McCallister, Dr. Linda Rhodes, Dr. Willie M. Reed, Frank D’Amelio, Gregory Norden, Juan Ramón Alaix, Louise M. Parent, Paul M. Bisaro, Robert Scully, Sanjay Khosla, William Steere, Jr.
 

Company data

Name: Zoetis Inc.
Address: 10 Sylvan Way,Parsippany, New Jersey 07054, USA
Phone: +1-973-822-7000
Fax: -
E-mail: -
Internet: www.zoetis.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 84.70%
IPO date: 2/1/2013

Investor relations

Name: Steve Frank
IR phone: +1-973-822-7141
IR-Fax: -
IR e-mail: steve.frank@zoetis.com

Company calendar

CW 23 | 6/3/2019 Dividend Payment
 

Main Shareholders

Freefloat
 
84.70%
BlackRock Inc.
 
7.70%
The Vanguard Group
 
7.60%